ABIOMED Inc ABMD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:59 PM EST
324.83quote price arrow up+3.14 (+0.98%)
Volume
107,312
52 week range
119.01 - 387.40

...

Loading . . .

KEY STATS

  • Open320.40
  • Day High327.73
  • Day Low316.75
  • Prev Close321.69
  • 52 Week High387.40
  • 52 Week High Date01/28/21
  • 52 Week Low119.01
  • 52 Week Low Date03/23/20
  • Market Cap14.692B
  • Shares Out45.23M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • 1 Year % Change96.73

RATIOS/PROFITABILITY

  • EPS (TTM)4.39
  • P/E (TTM)73.92
  • Fwd P/E (NTM)71.83
  • EBITDA (MRQ)248.079M
  • ROE (MRQ)17.37%
  • Revenue (MRQ)812.94M
  • Gross Margin (MRQ)80.91%
  • Net Margin (MRQ)24.66%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date04/28/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest ABIOMED Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and...
Michael Minogue
Chairman
David Weber Ph.D.
Chief Operating Officer
Todd Trapp
Chief Financial Officer
Andrew Greenfield
Vice President
Michael Howley
Vice President
Address
22 CHERRY HILL DR
Danvers, MA
01923-2575
United States